Results 81 to 90 of about 217,451 (307)
The osteocyte lacunar network changes in alcoholic liver cirrhosis: an autopsy study
, 2022 Jelena Jadžić +7 more
openalex +1 more source
Feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patients [PDF]
, 2020 Olga R. Brook +11 more
openalex +1 more source
Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky +8 more
wiley +1 more source
The problem with autopsy today may be us
Autopsy and Case Reports, 2020 Jody E. Hooper
doaj +1 more source
Research progress of psychological autopsy and its enlightenment to suicide research of inpatient
Huli yanjiu, 2021 To summarize concept of psychological autopsy，research content of psychological autopsy，promotion of psychological autopsy on suicide theory，and development of research methods of psychological autopsy.It also compared psychological autopsy with other ...
WU Ming'e +3 more
doaj
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective The Gold Coast criteria permit diagnosis of amyotrophic lateral sclerosis (ALS) even without upper motor neuron (UMN) signs. However, whether ALS patients with UMN signs (ALSwUMN) and those without (ALSwoUMN) share similar characteristics and prognoses remains unclear.
Hee‐Jae Jung +7 more
wiley +1 more source
Heart Rhythm O2Background: Autopsy, the gold standard for determining the cause of death, is declining globally. Significant differences exist between clinical diagnoses and those revealed at autopsy.
Dean M. Nelson, BBiomed, MD +8 more
doaj +1 more source
Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To determine the test performance of cutaneous phosphorylated alpha‐synuclein (P‐SYN) in dementia with Lewy bodies (DLB), individuals with reduced Montreal Cognitive Assessment (MoCA) and healthy controls. Methods This is the first subgroup analysis of the Synuclein‐One study, a prospective, blinded study evaluating P‐SYN detection ...
Christopher H. Gibbons +31 more
wiley +1 more source